ARTICLE | Clinical News
FDA committee: 60 Degrees' malaria candidate safe and effective
July 27, 2018 5:18 PM UTC
FDA's Antimicrobial Drugs Advisory Committee voted that malaria candidate Arakoda tafenoquine (60P003) from 60 Degrees Pharmaceuticals LLC (Washington, D.C.) is effective and safe.
The panel voted 11-2 that tafenoquine was effective in preventing malaria infection in adults for up to six months of continuous dosing, and voted 9-4 that the product was safe. The 8-aminoquinoline is under Priority Review...
BCIQ Company Profiles